MedPath

Cranioplasty Using Titanium Mesh Vs Bone Cement

Phase 2
Not yet recruiting
Conditions
Bone Defects
Decompressive Craniectomy and Cranioplasty
Cranioplasty
Registration Number
NCT06662903
Lead Sponsor
Osman Hassan Osman Zafraan
Brief Summary

The aim of this study is:

To compare the surgical outcomes between titanium mesh and bone cement in cranioplasty.

To assess the complication rates associated with each material. To evaluate patient satisfaction and aesthetic results post-surgery

Detailed Description

Cranioplasty is a common neurosurgical procedure performed to repair skull vault defects.

The skull vault defects may result mostly after traumatic injuries as depressed skull fractures, Tumor removal (infiltrating skull bones), decompressive craniectomies, congenital anomalies or inflammatory lesions.

At present, there is no gold standard material for cranioplasty with the use of autologous bone as well as other synthetic materials as bone cement and titanium mesh.

Bone cement is malleable, lightweight, strong, and heat resistant, but it may cause burn injury during the process of its preparation and is used for relatively small defects.

Titanium mesh good mechanical strength, a low infection rate, and an acceptable cost but may cause metal allergy, tissue erosion, implant exposure, and deformity upon application of external force.

Cranioplasty not only provides Brain protection and cosmetic aspects but also, decrease incidence of epilepsy, relief to psychological drawbacks and increases social performance, restoring the dynamics of CSF.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Patients requiring cranioplasty for a skull defect due to Decompressive Craniectomy, trauma, tumor resection, or congenital issues.
    • All ages .
    • Both sex.
    • Informed consent obtained from all participants.
    • Patient fit for surgery.
Exclusion Criteria
  • Patients with active infection at the surgical site
    • Patient Unfit for surgery.
    • Patient refuse consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Patient satisfaction using patient ssatisfaction gradethrough study completion, an average 1 years

Patients satisfaction (cosmetic, psychological, neurologic ) measered by validate questionnaire post-opeartive and follow up using Patient satisfaction grade from Excellent to not satisfied

Secondary Outcome Measures
NameTimeMethod
Infectionthrough study completion, an average 1 years

follow up rate of post operative infection

Reoperationthrough study completion, an average 1 years

rate of reoperation after using each material a post-operative follow up

CSF leakthrough study completion, an average 1 years

post-operative complication of CSF leak due to changes in Dynamics of CSF flow

complicationsthrough study completion, an average 1 years

post-operative as hematoma formation , neurologic defict and fits.

Trial Locations

Locations (1)

Assuit University Hospital

🇪🇬

Asyut, Egypt

© Copyright 2025. All Rights Reserved by MedPath